CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
Category: Health Insurance and Managed Care
-
UnitedHealth’s Move to End Cyberattack Loan Lifeline Upsets Medical Providers
The company lent roughly $9 billion to practices affected by a vast cyberattack on its payment systems last year. Medical practices are now suing the health care colossus, saying it is pressuring them to repay funds.
-
U.S. Prosecutors Accuse Large Insurers of Paying Kickbacks for Private Medicare Plans
The Justice Department accused large insurers of colluding with national brokers to steer older people and those with disabilities toward coverage that might not offer the best medical care.
-
Medicare Bleeds Billions on Pricey Bandages, and Doctors Get a Cut
Medicare spending on “skin substitutes” made of dried placenta has soared as doctors pocket lucrative discounts from sellers.
-
More Americans Cannot Afford Medical Care: Gallup Poll
A new survey found that 11 percent of Americans said they could not pay for medication and medical treatments.
-
Obamacare Could See Big Changes in 2026
A proposed rule would restrict “eligibility, enrollment and affordability” in plans under the Affordable Care Act, health policy analysts say.
-
Senators Grill Dr. Oz on Medicaid Cuts and Medicare Changes
Dr. Mehmet Oz, the TV celebrity, dodged queries about Republican plans to cut health insurance for the poor, and emerged unscathed on his ties to major industries.
-
How Much Should Weight Loss Drugs Like Wegovy and Zepbound Cost?
A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are now.
-
Dr. Oz Faces Senators at Confirmation Hearing to Oversee Medicare and Medicaid
The Senate Finance Committee holds a confirmation hearing on Friday for Dr. Mehmet Oz, the TV celebrity who is nominated to run major health programs for older Americans and the poor.
-
Weight Loss Drug Will Be Offered for $499 a Month for Some Patients
Some commercially insured patients stand to save $150 per month on Wegovy, a popular obesity medication. Patients on Medicare and Medicaid are not eligible.
-
Dr. Oz: How His Millions Collide With Medicare
The TV celebrity and Trump nominee has pledged to divest from most of his financial interests. But they touch nearly every corner of health care, from insurance to blood pressure cuffs and vitamins, leading experts and lawmakers to doubt he could make impartial decisions.
-
Chinese Hospital Bankruptcies Soar Amid Financial Strains
Still recovering from heavy spending during the pandemic, hospitals are squeezed by a slumping economy and government efforts to curb health care spending.